Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice

Abstract Toxoplasma gondii and Neospora caninum are closely related apicomplexan parasites. The surface antigen 1 of T. gondii (TgSAG1) is a major immunodominant antigen and, therefore, is considered to be a good candidate for the development of an effective recombinant vaccine against toxoplasmosis...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 28; no. 45; pp. 7243 - 7247
Main Authors Zhang, Guohong, Huang, Xiaohong, Boldbaatar, Damdinsuren, Battur, Banzragch, Battsetseg, Badgar, Zhang, Houshuang, Yu, Longzheng, Li, Yan, Luo, Yuzi, Cao, Shinuo, Goo, Youn-Kyong, Yamagishi, Junya, Zhou, Jinlin, Zhang, Shoufa, Suzuki, Hiroshi, Igarashi, Ikuo, Mikami, Takeshi, Nishikawa, Yoshifumi, Xuan, Xuenan
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 21.10.2010
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Toxoplasma gondii and Neospora caninum are closely related apicomplexan parasites. The surface antigen 1 of T. gondii (TgSAG1) is a major immunodominant antigen and, therefore, is considered to be a good candidate for the development of an effective recombinant vaccine against toxoplasmosis. In this study, N. caninum stably expressing the TgSAG1 gene (Nc/TgSAG1) was constructed using pyrimethamine-resistant DHFR-TS and GFP genes as double-selection markers. The expression level, molecular weight, and antigenic property of recombinant TgSAG1 expressed by the Nc/TgSAG1 were similar to those of the native TgSAG1. The mice immunized with Nc/TgSAG1 induced TgSAG1-specific Th1-dominant immune responses and protected the mice from a lethal challenge infection with T. gondii . These results indicate that N. caninum may provide a new tool for the production of a live recombinant vector vaccine against toxoplasmosis in animals. To our knowledge, this is the first report to evaluate the usefulness of N. caninum -based live vaccine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2010.08.096